[Clinical and Economic Evaluation of the Introduction of the Combinazion Trametinib + Dabrafenib in the Management of Advanced Melanoma in the Italian Market]. FE 2016, 17 (3S), 1-32. https://doi.org/10.7175/fe.v17i3S.1279.